Companies: 10,795·Total market cap: $144.5T
OptimizeRx Corporation

OptimizeRx Corporation

OPRXNASDAQHealthcare● Active
$5.05
$-0.06(-1.17%)
Market Cap$94763629
P/E Ratio
52W High$22.25
52W Low$4.57
Overview

OptimizeRx Corporation (OPRX) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · OPRX · as of Jun 9, 2026

Key Statistics

EPS (TTM)$0.37oprx eps ttm · oprx earnings per shareEarnings history
PE Ratio (TTM)13.8×oprx pe ratio ttm · oprx price to earningsPE Ratio deep dive
Revenue (TTM)$107.3Moprx revenue ttm · oprx annual revenueFull revenue history
Dividend YieldNo Dividenddoes oprx pay dividends · oprx dividend yieldDividend history
Shares Outstanding18.6Moprx shares outstanding · oprx floatShares outstanding history
Next EarningsAug 6, 2026Est.oprx earnings date · oprx next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$109.4M▲ +18.78% YoY
202320242025
optimizerx corporation revenue · oprx revenue 2025
FY 2025Net Income$5.1M▲ +125.52% YoY
202320242025
optimizerx corporation net income · oprx profit 2025
FY 2025EPS$0.28▲ +125.45% YoY
202320242025
oprx eps · optimizerx corporation earnings per share 2025
TTM:Revenue: $107.3MNet Income: $6.8MEPS: $0.37View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy15 analystsis oprx a buy · oprx analyst rating
Strong Buy
0
Buy
11
Hold
4
Sell
0
Strong Sell
0
12-Month Price Target
$7.00Low
$5.05Current
$10.50Avg Target107.92% upside
$14.00High
oprx price target · oprx 12 month forecast

Total: 15 · Buy rate: 73.3%

The OPRX analyst consensus is Buy, based on ratings from 15 Wall Street analysts over the past 3 months. The average 12-month price target is $10.50, representing +107.92% upside from the current price of $5.05.

Stock Performance

Full History
1D-0.78%
1W-3.24%
1M-21.27%
3M-24.78%
YTD-58.65%
1Y-65.65%
5Y-90.40%

About OptimizeRx Corporation

CEOStephen L. Silvestro
IPO DateNov 28, 2007
Employees128
CountryUS

OptimizeRx Corporation is a digital health technology firm delivering a broad spectrum of solutions to life sciences organizations, healthcare providers, and patients. Its core offerings encompass fin…

what is optimizerx corporation · oprx stock overview · optimizerx corporation company profile · who is optimizerx corporation ceo · oprx NASDAQ · optimizerx corporation headquarters · optimizerx corporation business segments

About Stock Overview & Key Data

OptimizeRx Corporation (OPRX) is a Healthcare company in the Medical - Healthcare Information Services industry, listed on NASDAQ since Nov 28, 2007. As of the latest trading session, OPRX stock price is $5.05, with a market capitalization of $94.8M. The stock has returned -65.65% over the past 12 months and -58.65% year-to-date.

According to 15 Wall Street analysts, the consensus rating for OptimizeRx Corporation stock is Buy, with an average 12-month price target of $10.50. In fiscal year 2025, OptimizeRx Corporation reported revenue of $109.4M and net income of $5.1M. For detailed data — including OptimizeRx Corporation revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, OptimizeRx Corporation (OPRX) stock price is $5.05. The stock is traded on NASDAQ under the ticker symbol OPRX. The 52-week range is $4.57 – $22.25.

OPRX stock priceOPRX quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice